121 related articles for article (PubMed ID: 25755903)
1. Congenital oligodendroglioma: clinicopathologic and molecular assessment with review of the literature.
Richard H; Stogner-Underwood K; Fuller C
Case Rep Pathol; 2015; 2015():370234. PubMed ID: 25755903
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of chromosome 1p and 19q status and expression of R132H mutant IDH1 protein in oligodendroglial tumors].
Yao K; Duan Z; Hu Z; Bian Y; Qi X
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):663-7. PubMed ID: 25567591
[TBL] [Abstract][Full Text] [Related]
3. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
Sathornsumetee S; Cheunsuchon P; Sangruchi T
World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
[TBL] [Abstract][Full Text] [Related]
4. Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.
Schniederjan MJ; Alghamdi S; Castellano-Sanchez A; Mazewski C; Brahma B; Brat DJ; Brathwaite CD; Janss AJ
Am J Surg Pathol; 2013 May; 37(5):763-71. PubMed ID: 23588371
[TBL] [Abstract][Full Text] [Related]
5. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B
Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340
[TBL] [Abstract][Full Text] [Related]
6. The Applicability of Haarlem Integrated Diagnostic System in Diffuse Glial Tumors and Molecular Methods Affecting Prognosis.
Kaya Terzi N; Yılmaz İ; Öz AB
Balkan Med J; 2019 Jul; 36(4):222-228. PubMed ID: 30592195
[TBL] [Abstract][Full Text] [Related]
7. Case report: Spinal drop metastasis of IDH-mutant, 1p/19q-codeleted oligodendroglioma.
Karaman AK; Korkmazer B; Urganci N; Baş G; Arslan S; Comunoglu N; Hanci MM; Kızılkılıç O
Front Neurol; 2022; 13():1086591. PubMed ID: 36588881
[TBL] [Abstract][Full Text] [Related]
8. A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2.
Park JH; Cha YJ; Chang JH; Lee SK; Kim SH
Brain Tumor Pathol; 2020 Jul; 37(3):95-99. PubMed ID: 32504153
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
[TBL] [Abstract][Full Text] [Related]
10. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
11. MRI and CT Identify Isocitrate Dehydrogenase
Patel SH; Batchala PP; Mrachek EKS; Lopes MS; Schiff D; Fadul CE; Patrie JT; Jain R; Druzgal TJ; Williams ES
Radiology; 2020 Jan; 294(1):160-167. PubMed ID: 31714193
[TBL] [Abstract][Full Text] [Related]
12. Dysembryoplastic neuroepithelial tumor (DNT)-like oligodendrogliomas or Dnts evolving into oligodendrogliomas: two illustrative cases.
Gonzales M; Dale S; Susman M; Nolan P; Ng WH; Maixner W; Laidlaw J
Neuropathology; 2007 Aug; 27(4):324-30. PubMed ID: 17899685
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
15. Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted.
Ballester LY; Dunbar E; Guha-Thakurta N; Henson JW; Chandler H; Watkins J; Fuller GN
Front Neurol; 2018; 9():700. PubMed ID: 30210430
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
18. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
[TBL] [Abstract][Full Text] [Related]
19. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
[TBL] [Abstract][Full Text] [Related]
20. Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.
Raghavan R; Balani J; Perry A; Margraf L; Vono MB; Cai DX; Wyatt RE; Rushing EJ; Bowers DC; Hynan LS; White CL
J Neuropathol Exp Neurol; 2003 May; 62(5):530-7. PubMed ID: 12769192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
